GOVX
Biotechnology · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when GeoVax Labs, Inc. publishes a filing, an earnings call transcript or a press release.
Get GOVX alertsMark Reynolds is recorded as CFO at GeoVax Labs, Inc. (GOVX). The newest filing on record that lists Mark Reynolds as CFO at GeoVax Labs, Inc. (GOVX) is dated April 27, 2026. The proxy statement of GeoVax Labs, Inc. reports total compensation of $421,400 for Mark Reynolds in fiscal 2022, including a base salary of $240,000. Disclosed compensation is on record for 5 fiscal years. Mark Reynolds has spoken on 19 earnings calls across 1 company, most recently for GeoVax Labs, Inc. on November 13, 2025. GeoVax Labs, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at GeoVax Labs, Inc. includes David A. Dodd (CEO and Board Member), Dean G. Kollintzas (Board Member), Jayne Morgan (Board Member) and 6 others.
“And the details of our third quarter financial results are summarized in today's press release. I'll start the review with our income statement. During the 9 months ended September 30, 2025, we reported revenues of $2.5 million versus $3.1 million in 2024.”
“The details of our first quarter 2025 financial results are summarized in today's press release. I'll start my review with our income statement. Revenues associated with the BARDA contract were $1.6 million in 2025 versus zero in 2024 as the contract began during June of last year.”
“Our contract with BARDA began on June 12. So, there were minimal revenues reported during the second quarter. But during the third quarter ended September 30, we reported $2.8 million of revenues and $3.1 million for the nine-month period.”
“I'll begin with a brief review of our income statement. The first thing to comment on is that we had no grant revenues or government contracts during the first quarter, as we've reported in the past years.”
Start not stated–present
Last confirmed April 27, 2026
GOVX
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | GeoVax Labs, Inc. (GOVX) | Chief Financial Officer | $240,000 | $421,400 |
| 2021 | GeoVax Labs, Inc. (GOVX) | Chief Financial Officer | $234,392 | $478,326 |
| 2020 | GeoVax Labs, Inc. (GOVX) | Chief Financial Officer | $234,392 | $500,751 |
| 2019 | GeoVax Labs, Inc. (GOVX) | Chief Financial Officer | $234,392 | $240,017 |
| 2018 | GeoVax Labs, Inc. (GOVX) | Chief Financial Officer | $234,392 | $253,406 |